Author:
Chandra Fiona,Zaks Lihi,Zhu Andy
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Voskoglou-Nomikos T, Pater J, Seymour L. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin Cancer Res. 2003;9:4227–39.
2. Lai Y, Wei X, Lin S, Qin L, Cheng L, Li P. Current status and perspectives of patient-derived xenograft models in cancer research. J Hematol Oncol. 2017;10:106.
3. Morgan K, Riedlinger G, Rosenfeld J, et al. Patient-derived xenograft models of non-small cell lung cancer and their potential utility in personalized medicine. Front Oncol. 2017;7:2.
4. Zhu A. Quantitative translational modeling to facilitate preclinical to clinical efficacy and toxicity translation in oncology. Future Sci OA. 2018;4:FSO306.
5. Simeoni M, Magni P, Cammia C, de Nicolao G, Croci V, Pesenti E, et al. Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents. Cancer Res. 2004;64:1094–101.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献